Merci, Monsieur le President. I seem to be on a real roll, here, so thanks again to the Minister for the work that he does on this issue. I know that he also participates in federal-provincial-territorial conferences and working groups. I mentioned earlier in my statement about the tendency of our federal government to promote so-called free trade agreements that extend protection for drug manufacturers, sometimes with little corresponding benefits. Can the Minister tell the House what positions our government has put forward in the so-called free trade agreement negotiations with regard to prescription drugs? Mahsi, Mr. Speaker.
Kevin O'Reilly on Question 155-18(3): Pharmacare And Prescription Accessibility
In the Legislative Assembly on February 23rd, 2018. See this statement in context.
Question 155-18(3): Pharmacare And Prescription Accessibility
Oral Questions
February 22nd, 2018
See context to find out what was said next.